Abbott Defends Patent Board’s Obviousness Holdings In Appellee Brief
WASHINGTON, D.C. — The Patent Trial and Appeal Board correctly concluded that “comprising” claim language in a vascular stent patent is “open-ended” and “consistent” with the term’s “well-understood meaning,” Abbott Vascular...To view the full article, register now.
Already a subscriber? Click here to view full article